Health & Science Policy

Latest AACC Position Statements

Direct-to-Consumer Laboratory Testing

DTC laboratory testing is a key element of ongoing efforts to increase individuals’ engagement in managing their healthcare, and it is critical that DTC test results are accurate and well understood. Laboratory professionals play a vital role in this process.

Advancing Personalized/Precision Medicine

Laboratory medicine is key to enabling the practice of precision medicine. Policymakers and payers should adopt policies that ensure access to and appropriate reimbursement for laboratory testing that will facilitate personalized therapeutic decisions.

Oversight of Laboratory Developed Tests

Laboratory Developed Tests provide timely, accurate, quality testing for many conditions for which no commercial test exists or when an existing test does not meet current clinical needs. The regulation of LDTs should remain under CLIA’88 and its deemed accreditation bodies, except for certain high risk tests that should be subject to both FDA and CMS oversight.

Newborn Screening and Improving Childrens Health

AACC endorses public-private efforts to maintain, improve, and expand newborn screening programs. The Association also supports evidence-based efforts to identify additional conditions for screening and the use of residual specimens for quality assurance and continuous improvements in pediatric healthcare.

Health & Science Policy Articles